Unwanted intravascular material and its consequences w/Case studies. Use of AngioVac Gen 3 - Day 1
Unwanted intravascular material and its consequences w/Case studies. Use of AngioVac Gen 3 - Day 1

Unwanted intravascular material and its consequences w/Case studies. Use of AngioVac Gen 3 - Day 1 [108]

  • Faculty: Program director Joseph Basha, CCP
  • Date: December 10th, 2019 1:45 pm
  • CE’s: 3 CEs
  • Price: $45
  • Category 1 SDCE CEU
Buy Course
Course Rating:
(0 Reviews)

Latest Reviews

View All

Course description

Perfweb #31 - Day 1
Topics for this program: Unwanted intravascular material and its consequences w/Case studies 
Introducing the AngioVac Gen 3 
Incorporating AngioVac Gen 3 into a comprehensive Pulmonary Embolism (PE) Response program 
Use of AngioVac with Oxygenation and MCS (Demonstration) __________________________________________________________________ 
Follow Us on Twitter: https://twitter.com/nola_conference __________________________________________________________________  
#perfusion #angiovac #pulmonaryembolism 
 _________________________________________________________________ 
 Please visit our sponsor links below: 

Meet Your Instructor

Program director Joseph Basha, CCP

Program director Joseph Basha, CCP

Joseph has been a practicing clinical perfusionist for 40 years. Currently, Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference and MediWeb which includes PerfWeb and NurseWeb.

Read full bio